Chronic Lung Disease: A Study Based on the National Database of Specified Chronic Pediatric Diseases of Japan

Fumihiko Namba1

  • 1Department of Pediatrics, Saitama Medical Center, Saitama Medical University, Saitama, Japan.

Insights

This study reveals chronic lung disease (CLD) in Japan affects diverse infants, including many term infants with comorbidities. Invasive respiratory support in extremely preterm infants predicts ongoing CLD support needs.

Area of Science:

  • Pediatrics
  • Neonatology
  • Pulmonology

Background:

  • Chronic lung disease (CLD), often bronchopulmonary dysplasia, is a key pediatric disease in Japan, primarily affecting premature infants.
  • Characteristics of CLD patients in the National Database of Specified Chronic Pediatric Diseases remain underexplored.

Purpose of the Study:

  • To elucidate the characteristics of children with CLD registered in Japan's National Database of Specified Chronic Pediatric Diseases.
  • To identify factors associated with persistent CLD support needs.

Main Methods:

  • Analysis of Medical Certificates of Specific Chronic Pediatric Diseases for CLD patients registered between January 2015 and March 2023.
  • Inclusion of data from 1737 identified CLD patients, with subgroup analysis of 805 extremely preterm infants.

Main Results:

  • CLD patients comprised 47% extremely preterm and 24% term infants, with regional variations.
  • Neurological disorders (43%) and chromosomal abnormalities (19%) were common in term infants with CLD.
  • Invasive mechanical ventilation at 36 weeks postmenstrual age was linked to persistent CLD support (OR 3.16).

Conclusions:

  • Registry-defined CLD in Japan is heterogeneous, including many term infants with comorbidities.
  • Extremely preterm infants needing invasive respiratory support require ongoing management.
  • Optimizing long-term care strategies for CLD patients is crucial.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.